- Home
- IGC vs FENG Comparison
IGC vs FENG Comparison
Compare IGC & FENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- FENG
- Stock Information
- Founded
- IGC 2005
- FENG 1998
- Country
- IGC United States
- FENG China
- Employees
- IGC N/A
- FENG N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- FENG Broadcasting
- Sector
- IGC Health Care
- FENG Industrials
- Exchange
- IGC Nasdaq
- FENG Nasdaq
- Market Cap
- IGC 29.4M
- FENG 29.7M
- IPO Year
- IGC N/A
- FENG 2011
- Fundamental
- Price
- IGC $0.31
- FENG $2.16
- Analyst Decision
- IGC Strong Buy
- FENG
- Analyst Count
- IGC 2
- FENG 0
- Target Price
- IGC $3.88
- FENG N/A
- AVG Volume (30 Days)
- IGC 392.1K
- FENG 12.2K
- Earning Date
- IGC 02-18-2025
- FENG 03-18-2025
- Dividend Yield
- IGC N/A
- FENG N/A
- EPS Growth
- IGC N/A
- FENG N/A
- EPS
- IGC N/A
- FENG N/A
- Revenue
- IGC $1,236,000.00
- FENG $99,426,474.00
- Revenue This Year
- IGC N/A
- FENG N/A
- Revenue Next Year
- IGC $18.34
- FENG N/A
- P/E Ratio
- IGC N/A
- FENG N/A
- Revenue Growth
- IGC 1.64
- FENG N/A
- 52 Week Low
- IGC $0.26
- FENG $1.50
- 52 Week High
- IGC $0.91
- FENG $4.15
- Technical
- Relative Strength Index (RSI)
- IGC 52.84
- FENG 40.74
- Support Level
- IGC $0.26
- FENG $2.15
- Resistance Level
- IGC $0.34
- FENG $2.32
- Average True Range (ATR)
- IGC 0.02
- FENG 0.20
- MACD
- IGC 0.01
- FENG -0.04
- Stochastic Oscillator
- IGC 65.88
- FENG 26.17
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.